CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 165 filers reported holding CLOVIS ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $518 | – | 16,795 | +6618.0% | 0.08% | – |
| Q4 2022 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 250 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 250 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 250 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $3,000 | +200.0% | 250 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -75.0% | 250 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $4,000 | -42.9% | 250 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |